IO Biotech, Inc. (IOBT) Financials

IOBT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 150.7 million 17.6 million
2023-09-30 172.6 million 15.0 million
2023-06-30 117.6 million 13.0 million
2023-03-31 136.8 million 12.6 million

IOBT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -22.9 million 1.6 million
2023-09-30 -16.0 million 3.0 million
2023-06-30 -18.3 million 1.6 million
2023-03-31 -14.8 million 1.9 million

IOBT Net Income

No data available :(

IOBT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 143.2 million - 2.5 million
2023-09-30 165.5 million - 2.6 million
2023-06-30 110.1 million - 2.8 million
2023-03-31 128.5 million - 2.8 million

IOBT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 65.9 million
2023-09-30 50.2 million
2023-06-30 28.8 million
2023-03-31 28.8 million

IOBT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 112000 21.8 million 6.4 million -201000
2023-09-30 24000 17.7 million 5.8 million -
2023-06-30 39000 16.5 million 5.3 million -
2023-03-31 148000 11.9 million 6.0 million -

IOBT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 201000
2023-09-30 - 194000
2023-06-30 - 187000
2023-03-31 - 174000

IOBT

Price: $1.57

52 week price:
0.82
2.64

Earnings Per Share: -1.98 USD

P/E Ratio: -0.70

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 106527

Market Capitalization: 102.1 million

Links: